摘要

The search for novel lead from the group of various substituted N-piperazine ether derivatives was performed. Acyl- and pyridylpiperazine ethyl/propyl ethers were obtained via three different synthetic pathways. Affinity to histamine H-3 receptor was established, as well as, for selected compounds, selectivity towards histamine H4R. Docking studies to the histamine H3R homology model strengthened the position of (4-(3-(4-(3-chlorobenzoyl)piperazin-1-yl) propoxy)phenyl)(cyclopropyl) methanone (compound 26) as a novel lead for further studies on histamine H3 receptor antagonist/inverse agonist.

  • 出版日期2014